<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although survival rates of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> patients diagnosed at an early stage (T1-2N0M0; Dukes A) vary considerably according to the studies cited, several studies indicate development of distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> already occurring in a considerable percentage of these patients leading to the <z:hpo ids='HP_0011420'>death</z:hpo> of the patients </plain></SENT>
<SENT sid="1" pm="."><plain>This particular high risk group cannot be identified properly as no marker exists to identify these patients </plain></SENT>
<SENT sid="2" pm="."><plain>As the Wnt/Win pathway plays a crucial role in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, we analysed whether the transcription factor brachyury critically involved in this pathway may predict <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation in these patients </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of brachyury-homologous (T) was immunohistochemically analysed in 748 patients and the data were correlated with classical and newer prognostic markers in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Early stages <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (T1-2N0M0, Dukes A) showed a significantly decreased survival when brachyury was expressed in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue while no correlation was observed in later <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stages </plain></SENT>
<SENT sid="5" pm="."><plain>Hence a subset of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> exists in which the ability to metastasise is already present at early stages of <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> and this high risk group can now be detected by immunohistochemistry </plain></SENT>
</text></document>